Skip to content
Traceability first — every claim on this site is published only once substantiated
PEPTIDERESEARCH
Approved for public listingCOA pending

5-amino-1MQ 50mg

Also referenced as: 5 amino 1mq · research · 5amino1mq · metabolic research

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT expression is elevated in adipose tissue and linked to metabolic dysfunction in research studies. NNMT-inhibitor research compound studied for energy metabolism, adiposity and body-composition pathways. This product is supplied as 50mg. Supplier availability or commercial vial strength should not be interpreted as a clinical dose or evidence of therapeutic efficacy. For laboratory research use only. Not intended for human consumption.

Research categories

Fields of laboratory research only. Not therapeutic claims, indications or evidence of efficacy.

$123.99

Not currently held in stock

This specification is not currently in stock. Submit a pre-order and we confirm availability by email from orders@peptideresearch.au before any payment is taken. Pre-orders receive a 10% discount off the confirmed price.

Specification
50mg
Form
Lyophilised powder or solution as supplied
Purity
[INFORMATION REQUIRED]
Purity method
[INFORMATION REQUIRED]
Identity method
[INFORMATION REQUIRED]
Batch
PR-2608
Lot
PR-2608-AMQ50
Storage
[INFORMATION REQUIRED]
Stock
Out of stock

Technical record

Documentation policy

Peptide Research publishes analytical values only where a certificate exists for the lot in question. Where a field reads pending, no verified source document has been supplied — we do not substitute typical or supplier-marketing values.

No human-use information

No dosage, reconstitution-for-administration, protocol or therapeutic-outcome information is published for any record on this site.

Related records

Approved for public listing

Adamax 10mg

Specification
10mg
Purity
Not published

Not currently held in stock